Cancer
Control
RTOG R0518
Consent
HIPAA
Protocol
Supplemental Funding
Pre-registration requirements (see protocol
section 5.0)
Phase
III, Double-Blind, Placebo-Controlled Study to
Evaluate the Efficacy of Zometa for the
Prevention of Osteoporosis and Associated
Fractures in Patients Receiving Radiation
Therapy and Long-term LHRH Agonists for
High-Grade and/or Locally Advanced Prostate
Cancer
RTOG R0517
Consent
HIPAA
Protocol
Pre-registration requirements (see protocol
section 5.0)
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
BRAIN
NCCTG RTOG 0525
Consent
HIPAA
Protocol
Phase II Trial Comparing
Conventional Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients
with Newly Diagnosed Glioblastoma
RTOG R0625 Consent
HIPAA
Protocol
Application
Information
(temporary closure)
A Randomized
Phase II Trial of Bevacizumab with Irinotecan or
Bevacizumab with Temozolomide in Recurrent
Glioblastoma
Brain Mets
NCCTG N0574
Consent
HIPAA
Protocol
Phase III Randomized Trial of the
Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients
with One to Three Cerebral Metastases
BREAST
NSABP B-39
Consent
HIPAA
Fast Facts
Protocol
(Closed to specific patients)
A Randomized Phase III Study of Conventional
Whole Breast Irradiation versus Partial Breast Irradiation for Women with Stage
0, I or II Breast Cancer
Breast - Metastatic
RTOG R0517
Consent
HIPAA
Protocol
Pre-registration requirements (see section 5.0
of the protocol)
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
GASTROINTESTINAL
Colon - Rectal
Rectal
NSABP R-04
Consent
HIPAA
Fast Facts
Protocol
A Clinical Trial Comparing Preoperative Radiation Therapy and
Capecitabine with Preoperative Radiation Therapy and Continuous Intravenous Infusion of
5-Fluorouracil in the Treatment of Patients with Operable Carcinoma of the Rectum
CTSU E5204
Consent
HIPAA
Fast Facts
Protocol
Intergroup
Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and
Leucovorin versus Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for
Patients with Stage II or III Rectal Cancer Receiving Preoperative
Chemoradiation
Stomach
SWOG S0425
Consent
HIPAA
Fast Facts Protocol
Neoadjuvant Chemoradiation Therapy with Oxaliplatin and Capecitabine for
Patients with Surgically Resectable Gastric Cancer: A Pilot Phase II Trial
with Molecular Correlates
CTSU
C80101
Consent
HIPAA
Fast Facts
Protocol
A Phase III
Intergroup Trial of Adjuvant Chemoradiation after Resection of Gastric or
Gastroesophageal Adenocarcinoma
Esophageal
SWOG S0356
Consent
HIPAA
Protocol
Oxaliplatin Plus
Protracted Infusion 5-Fluorouracil and Radiation for Potentially Curable
Esophageal Cancer: A Phase II Trial with Molecular Correlates
Pancreas
Gallbladder
GENITOURINARY
Prostate
CTSU MDA-3410
Consent
HIPAA
Fast Facts
Protocol
A Prospective Randomized Phase II Trial Comparing
Consolidation Therapy With or Without Strontium-89 Following Induction
Chemotherapy in Androgen-Independent Prostate Cancer
CTSU RTOG 0415
Consent
HIPAA
Fast Facts
Protocol
Pre-registration requirements (see section 5.0
of the protocol)
A Phase III Randomized Study of Hypofractinated 3D-CRT/IMRT Versus
Conventionally Fractionated 3D-CRT/IMRT in Patients with Favorable-Risk Prostate
Cancer
CTSU RTOG 0521
Consent Consent
for Tissue HIPAA
Protocol
Pre-registration requirements (see section 5.0
of the protocol)
A Phase III Protocol of
Androgen Suppression (AS) and Radiotherapy (RT) vs AS and RT Followed by
Chemotherapy with Doxetaxel and Prednisone for Localized High-Risk Prostate
Cancer
RTOG R0518
Consent
HIPAA
Protocol
Supplemental Funding
Pre-registration requirements (see section 5.0
of the protocol)
Phase
III, Double-Blind, Placebo-Controlled Study to
Evaluate the Efficacy of Zometa for the
Prevention of Osteoporosis and Associated
Fractures in Patients Receiving Radiation
Therapy and Long-term LHRH Agonists for
High-Grade and/or Locally Advanced Prostate
Cancer
RTOG R0517
Consent
HIPAA
Protocol
Pre-registration requirements (see section 5.0
of the protocol)
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
RTOG 0534
Consent
HIPAA
Protocol
A Phase III Trial
Of Short Term Androgen Deprivation With Pelvic
Lymph Node Or Prostate Bed Only Radiotherapy
(SPORT) In Prostate Cancer Patients With A
Rising PSA After Radical Prostatectomy
Bladder/Urothelium
Germ Cell Malignancies
Renal
GYNECOLOGIC
Ovarian
Cervical
CTSU GOG 0219
Consent
HIPAA
Fast Facts
Protocol
A Phase III Randomized Trial of Weekly
Cisplatin and Radiotherapy versus Cisplatin and Tirapazamine and Radiotherapy in
Stage IB2, IIA, IIIB, and IVA Cervical Cancer Limited to the Pelvis
Endometrial
HEAD & NECK
CTSU RTOG 0522
Consent HIPAA
Fast
Facts
Protocol
PET Requirements and
Credentialing
A Phase III Trial of
Concurrent Accelerated Radiation and Chemotherapy vs Concurrent Accelerated
Radiation, Chemotherapy and Cetuximab (C225) for Stage III and IV Head and Neck
Carcinoma
RTOG
R0435
Consent
HIPAA
Protocol
Training
Pre-registration requirements (see section 5.0
of the protocol)
Randomized, Phase III,
Double-Blind,
Placebo-Controlled Study to Evaluate the
Efficacy and Safety of Palifermin (NSC#740548m
IND 6370) for the Reduction of Oral Mucositis in
Patients with Locally-Advanced Head and Neck
Cancer Receiving Radiation Therapy with
concurrent Chemotherapy (Followed by surgery for
Selected Patients)
LEUKEMIA
Acute Leukemia
Chronic Leukemia
LUNG
Non-Small Cell
SWOG
S0429
Consent
HIPAA
Fast Facts
Protocol
A Pilot
(Phase I) Study of Weekly Docetaxel and Cetuximab Chemoradiation for Poor
Risk Stage III Non-Small Cell Lung Cancer
NCCTG
N0422
Consent
HIPAA
Protocol
Cetuximab and Radiation in Elderly
and/or Poor Performance Status Patients with Locally Advanced Non-Small Cell
Lung Cancer: A Phase II Study to Evaluate Survival and Toxicity
RTOG R0517
Consent
HIPAA
Protocol
Pre-registration requirements (see section 5.0
of the protocol)
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
RTOG R0617
Consent
HIPAA
Protocol
A
Randomized Phase III Comparison of
Standard-Dose (60 Gy) Versus High-Dose (74
Gy) Conformal Radiotherapy with Concurrent
and Consolidation Carboplatin/Paclitaxel in
Patients With Stage IIIA/IIIB Non-Small Cell
Lung Cancer
Small
Cell
RTOG R0623 Consent
HIPAA
Protocol
A Phase II Trial of Combined Modality
Therapy with Growth Factor Support for Patients
with Limited Stage Small Cell Lung Cancer
LYMPHOMA
Hodgkin's
Non-Hodgkin's
SWOG 9704
Consent HIPAA
Fast Facts
Protocol
A Randomized Phase III Trial Comparing Early High Dose
Chemoradiotherapy and an Autologous Stem Cell
Transplant to Conventional Dose CHOP Chemotherapy (With Possible Late Autologous Stem Cell
Transplant) for Patients With Diffuse Aggressive Non-Hodgkin’s Lymphoma in the
High-Intermediate and High Risk International Classification Prognostic Groups
Mantle
Cell
Melanoma
Myeloma
Sarcoma
Other
Return to the Top
